From: Risk factors for lymphatic filariasis in two villages of the Democratic Republic of the Congo
Variable | Category | Antigenaemia modela | Microfilaraemia modela | ||||||
---|---|---|---|---|---|---|---|---|---|
Full model | Final model | Full model | Final model | ||||||
Adj OR (95% CI)b | P | Adj OR (95% CI)c | P | Adj OR (95% CI)b | P | Adj OR (95% CI)d | P | ||
Previous AH treatment | Levamisole (n = 117) | 0.41 (0.22–0.76) | 0.005 | 0.40 (0.21–0.76) | 0.005 | 0.40 (0.16–0.98) | 0.046 | 0.41 (0.17–0.99) | 0.048 |
(ref: no) | Mebendazole (n = 53) | 0.75 (0.35–1.61) | 0.460 | 0.77 (0.35–1.69) | 0.509 | 0.52 (0.17–1.52) | 0.237 | 0.56 (0.19–1.64) | 0.291 |
Albendazole (n = 52) | 0.79 (0.37–1.65) | 0.525 | 0.73 (0.34–1.55) | 0.414 | 0.36 (0.10–1.29) | 0.115 | 0.35 (0.10–1.24) | 0.104 | |
LR test random effect | 0.065 | 0.005 | 0.252 | 0.197 |